A Phase 1/2 Trial of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Native Thai Infants

Abstract

The Walter Reed Army Institute of Research (WRAIR) has produced a tetravalent live-attenuated dengue vaccine that has been well tolerated and immunogenic in U.S. adults and Thai children. As infants are considered by many as an important age group for vaccination in dengue-endemic countries, we evaluated the vaccine in Thai flavivirus-na ve infants who are at risk for dengue.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Nov 01, 2006
Accession Number
ADA481708

Entities

People

  • A. Kerdpanich
  • A. Nisalak
  • B. L. Innis
  • C. Aree
  • K. Tanakijaru
  • M. P. Mammen
  • R. J. Jarman
  • R. Samakoses
  • R. V. Gibbons
  • S. Chunsuttiwat
  • S. Hengprasert
  • S. Simasathien
  • V. Watanaveeradej
  • Y. Hutagalung

Tags

DTIC Thesaurus Topics

  • Antibodies
  • Blood
  • Dengue
  • Diseases And Disorders
  • Health
  • Health Care
  • Health Services
  • Hospitals
  • Immunogenicity
  • Medical Personnel
  • Pain
  • Proteins
  • Public Health
  • Vaccination
  • Vaccines
  • Virus Diseases
  • Viruses

Readers

  • Immunology
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Vector-Borne Disease and Entomology

Technology Areas

  • Biotechnology